Login / Signup

Patients of 75 years and over with ANCA-associated vasculitis have a lower relapse risk than younger patients: A multicentre cohort study.

Sara ThietartGuillaume BeinsePerrine SmetsAlexandre KarrasCarole PhilipponnetJean-François AugustoKhalil El KarouiRafik MesbahDimitri Titeca-BeauportMohamed HamidouPierre-Louis CarronFrançois MaurierKarim SacrePascal CohenEric LiozonClaire Blanchard-DelaunayAlex KostianovskyChristian PagnouxLuc MouthonLoïc GuillevinBenjamin TerrierXavier PuechalFor The French Vasculitis Study Group
Published in: Journal of internal medicine (2021)
AAV patients ≥75 years have a lower relapse risk than patients aged 65-75 years despite a lower probability of having received maintenance therapy with a combination of glucocorticoids and immunosuppressants, but they still benefit from such treatment regimen. This article is protected by copyright. All rights reserved.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • clinical trial
  • randomized controlled trial
  • mesenchymal stem cells
  • bone marrow
  • gene therapy